Drug Trial Radar · NCT05165485
Phase 4 COPD and Suboptimal Inspiratory Flow Rate
Last checked: Nov 19, 2026Latest source record: Dec 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
404
Actual
Start
Jan 7, 2022
Primary completion
Nov 13, 2023
Study completion Nov 20, 2023
Sponsor
- Lead sponsor
- Theravance BiopharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Viatris Inc.
- First posted
- Dec 21, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study is a randomized, double-blind, double-dummy, parallel-group study evaluating efficacy and safety of revefenacin vs. tiotropium in adults with severe to very severe COPD and suboptimal PIFR.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
RevefenacinDrug
Revefenacin 175 mcg administered once daily for 84 days via nebulization
TiotropiumDrug
Tiotropium 18 mcg administered once daily for 84 days via Spiriva HandiHaler®
Revefenacin PlaceboDrug
Placebo for Revefenacin administered once daily for 84 days via nebulization
Tiotropium PlaceboDrug
Placebo for Tiotropium administered once daily for 84 days via Spiriva HandiHaler®
Primary outcomes
What the sponsor says the trial is designed to measure.
- FEV1Time frame: Baseline, Day 85 following 84 days of dosing
Locations
76 sites in 1 country. Site status is shown where the registry gives one.
Theravance Biopharma Investigational Site
Jasper, Alabama
Theravance Biopharma Investigational Site
Phoenix, Arizona
Theravance Biopharma Investigational Site
Tucson, Arizona
Theravance Biopharma Investigational Site
Newport Beach, California
Theravance Biopharma Investigational Site
San Diego, California
Theravance Biopharma Investigational Site
Stockton, California
Theravance Biopharma Investigational Site
Upland, California
Theravance Biopharma Investigational Site
Lakewood, Colorado
Theravance Biopharma Investigational Site
Brandon, Florida
Theravance Biopharma Investigational Site
Clearwater, Florida
Theravance Biopharma Investigational Site site 2
Clearwater, Florida
Theravance Biopharma Investigational Site
Clearwater, Florida
Theravance Biopharma Investigational Site
Daytona Beach, Florida
Theravance Biopharma Investigational Site
Leesburg, Florida
Theravance Biopharma Investigational Site
Miami, Florida
Theravance Biopharma Investigational Site
Miami, Florida
Theravance Biopharma Investigational Site
Orlando, Florida
Theravance Biopharma Investigational Site
Ormond Beach, Florida
Theravance Biopharma Investigational Site
Sarasota, Florida
Theravance Biopharma Investigational Site
Tampa, Florida
Theravance Biopharma Investigational Site
Winter Park, Florida
Theravance Biopharma Investigational Site
Chicago Ridge, Illinois
Theravance Biopharma Investigational Site
River Forest, Illinois
Theravance Biopharma Investigational Site
Hammond, Indiana
Theravance Biopharma Investigational Site
Valparaiso, Indiana
Theravance Biopharma Investigational Site
Annapolis, Maryland
Theravance Biopharma Investigational Site
Columbia, Maryland
Theravance Biopharma Investigational Site
Oxon Hill, Maryland
Theravance Biopharma Investigational Site
Towson, Maryland
Theravance Biopharma Investigational Site
North Dartmouth, Massachusetts
Theravance Biopharma Investigational Site
Farmington Hills, Michigan
Theravance Biopharma Investigational Site
Saint Charles, Missouri
Theravance Biopharma Investigational Site
St Louis, Missouri
Theravance Biopharma Investigational Site
Missoula, Montana
Theravance Biopharma Investigational Site
Las Vegas, Nevada
Theravance Biopharma Investigational Site
Albuquerque, New Mexico
Theravance Biopharma Investigational Site
Bronxville, New York
Theravance Biopharma Investigational Site
Schenectady, New York
Theravance Biopharma Investigational Site
Charlotte, North Carolina
Theravance Biopharma Investigational Site
Hickory, North Carolina
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.